Margaret Kaczor
Stock Analyst at William Blair
(0.73)
# 3,714
Out of 4,784 analysts
26
Total ratings
40%
Success rate
-12.89%
Average return
Main Sectors:
Stocks Rated by Margaret Kaczor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Downgrades: Market Perform | n/a | $17.79 | - | 2 | Feb 12, 2025 | |
| CVRX CVRx, Inc. | Upgrades: Outperform | n/a | $12.49 | - | 3 | Jan 14, 2025 | |
| CBLL CeriBell | Initiates: Outperform | n/a | $19.46 | - | 1 | Nov 5, 2024 | |
| STIM Neuronetics | Downgrades: Market Perform | n/a | $3.77 | - | 4 | Aug 12, 2024 | |
| INGN Inogen | Upgrades: Outperform | n/a | $6.80 | - | 5 | Feb 15, 2024 | |
| SKIN The Beauty Health Company | Downgrades: Market Perform | n/a | $1.32 | - | 2 | Nov 14, 2023 | |
| NVRO Nevro | Downgrades: Market Perform | n/a | $5.84 | - | 2 | Aug 5, 2021 | |
| DVA DaVita | Downgrades: Market Perform | n/a | $150.22 | - | 2 | Sep 11, 2019 | |
| MDT Medtronic | Assumes: Market Perform | n/a | $87.63 | - | 1 | Jun 6, 2018 | |
| ABT Abbott Laboratories | Upgrades: Outperform | n/a | $130.82 | - | 3 | Jan 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $67.74 | - | 1 | Apr 27, 2017 |
STAAR Surgical Company
Feb 12, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $17.79
Upside: -
CVRx, Inc.
Jan 14, 2025
Upgrades: Outperform
Price Target: n/a
Current: $12.49
Upside: -
CeriBell
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $19.46
Upside: -
Neuronetics
Aug 12, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $3.77
Upside: -
Inogen
Feb 15, 2024
Upgrades: Outperform
Price Target: n/a
Current: $6.80
Upside: -
The Beauty Health Company
Nov 14, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.32
Upside: -
Nevro
Aug 5, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $5.84
Upside: -
DaVita
Sep 11, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $150.22
Upside: -
Medtronic
Jun 6, 2018
Assumes: Market Perform
Price Target: n/a
Current: $87.63
Upside: -
Abbott Laboratories
Jan 25, 2018
Upgrades: Outperform
Price Target: n/a
Current: $130.82
Upside: -
Apr 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $67.74
Upside: -